GB9326192D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9326192D0
GB9326192D0 GB939326192A GB9326192A GB9326192D0 GB 9326192 D0 GB9326192 D0 GB 9326192D0 GB 939326192 A GB939326192 A GB 939326192A GB 9326192 A GB9326192 A GB 9326192A GB 9326192 D0 GB9326192 D0 GB 9326192D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939326192A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB939326192A priority Critical patent/GB9326192D0/en
Publication of GB9326192D0 publication Critical patent/GB9326192D0/en
Priority to TW083111439A priority patent/TW291479B/zh
Priority to IS4244A priority patent/IS4244A/is
Priority to ZA9410056A priority patent/ZA9410056B/xx
Priority to MYPI94003410A priority patent/MY131641A/en
Priority to AU12743/95A priority patent/AU684877B2/en
Priority to CA002179402A priority patent/CA2179402A1/en
Priority to EP95903817A priority patent/EP0736028A1/en
Priority to APAP/P/1994/000706A priority patent/AP535A/en
Priority to US08/652,460 priority patent/US5633276A/en
Priority to PCT/EP1994/004220 priority patent/WO1995017405A1/en
Priority to JP7517174A priority patent/JPH09507057A/ja
Priority to IL112097A priority patent/IL112097A/en
Priority to SV1994000083A priority patent/SV1994000083A/es
Priority to CO94057739A priority patent/CO4340623A1/es
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB939326192A 1993-12-22 1993-12-22 Chemical compounds Pending GB9326192D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds
TW083111439A TW291479B (enExample) 1993-12-22 1994-12-08
IS4244A IS4244A (is) 1993-12-22 1994-12-16 Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra
ZA9410056A ZA9410056B (en) 1993-12-22 1994-12-19 Indoline derivatives method of preparation and use
MYPI94003410A MY131641A (en) 1993-12-22 1994-12-19 Indoline derivatives, process of preparation and use
JP7517174A JPH09507057A (ja) 1993-12-22 1994-12-20 インドリン誘導体、その製造法、および医薬としてのその用途
CA002179402A CA2179402A1 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals
AU12743/95A AU684877B2 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals
EP95903817A EP0736028A1 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals
APAP/P/1994/000706A AP535A (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and use.
US08/652,460 US5633276A (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and use
PCT/EP1994/004220 WO1995017405A1 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals
IL112097A IL112097A (en) 1993-12-22 1994-12-21 N- (POLYHYDRO- OXACYCLOALKANO £2, 3-g| INDOL-1-YLALKYL) (CYCLO) ALKANANILIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SV1994000083A SV1994000083A (es) 1993-12-22 1994-12-21 Derivados de indol, su preparacion y uso, ref. 1215ml/sv.
CO94057739A CO4340623A1 (es) 1993-12-22 1994-12-21 Derivados de indolina, metodo de preparacion y uso

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9326192D0 true GB9326192D0 (en) 1994-02-23

Family

ID=10747030

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939326192A Pending GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds

Country Status (15)

Country Link
US (1) US5633276A (enExample)
EP (1) EP0736028A1 (enExample)
JP (1) JPH09507057A (enExample)
AP (1) AP535A (enExample)
AU (1) AU684877B2 (enExample)
CA (1) CA2179402A1 (enExample)
CO (1) CO4340623A1 (enExample)
GB (1) GB9326192D0 (enExample)
IL (1) IL112097A (enExample)
IS (1) IS4244A (enExample)
MY (1) MY131641A (enExample)
SV (1) SV1994000083A (enExample)
TW (1) TW291479B (enExample)
WO (1) WO1995017405A1 (enExample)
ZA (1) ZA9410056B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
CZ291626B6 (cs) * 1996-03-08 2003-04-16 Takeda Chemical Industries, Ltd. Tricyklické sloučeniny, způsob výroby a použití
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
TW476758B (en) * 1996-12-10 2002-02-21 Bristol Myers Squibb Co Benzodioxole, benzofuran, dihydrobenzofuran and benzodioxane melatonergic agents
AU6540598A (en) * 1997-03-05 1998-09-22 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU727654B2 (en) * 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
JP2002516859A (ja) * 1998-06-05 2002-06-11 ブリストルーマイヤーズ スクイブ カンパニー メラトニン作動性薬剤であるヘテロ環シスシクロプロパン誘導体
ES2213022T3 (es) 1999-06-30 2004-08-16 Bristol-Myers Squibb Company Derivados de aminopirrolidina heterociclicos utiles como agentes melatonergicos.
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
EP1213290B1 (en) 1999-08-20 2005-04-20 Takeda Pharmaceutical Company Limited Dihydrobenzofuran derivatives, process for the preparation thereof and agents
AU1603401A (en) * 2000-03-17 2001-10-03 Alcon Universal Ltd Pyranoindoles for treating glaucoma
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
ES2172415B2 (es) 2000-07-28 2003-11-16 Univ Madrid Complutense Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
AU2002245104B2 (en) * 2000-12-11 2006-08-17 Testocreme, Llc Topical testosterone formulations and associated methods
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
PE20080122A1 (es) * 2006-03-20 2008-04-24 Takeda Pharmaceutical Agente profilactico o terapeutico para el sindrome de colon irritable
US8273761B2 (en) * 2006-12-08 2012-09-25 Takeda Pharmaceutical Company Limited Tricyclic compound and medical use thereof
ES2331274B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuesto de indolina.
RU2011107443A (ru) * 2008-07-30 2012-09-10 Феррер Интернасионал С.А. (ES) Индаценовые соединения, фармацевтическая композиция и лекарственное средство на их основе, способ их получения и способ лечения или профилактики состояний, связанных с нарушением функционирования систем, регулируемых мелатонином, с их помощью
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485539A1 (fr) * 1980-06-26 1981-12-31 Sori Soc Rech Ind Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
US4703052A (en) * 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones

Also Published As

Publication number Publication date
IS4244A (is) 1995-06-23
US5633276A (en) 1997-05-27
AP535A (en) 1996-09-16
WO1995017405A1 (en) 1995-06-29
IL112097A (en) 1998-06-15
ZA9410056B (en) 1995-10-18
MY131641A (en) 2007-08-30
SV1994000083A (es) 1995-07-24
EP0736028A1 (en) 1996-10-09
CA2179402A1 (en) 1995-06-29
CO4340623A1 (es) 1996-07-30
IL112097A0 (en) 1995-03-15
AP9400706A0 (en) 1995-01-31
TW291479B (enExample) 1996-11-21
JPH09507057A (ja) 1997-07-15
AU1274395A (en) 1995-07-10
AU684877B2 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
GB9304618D0 (en) Chemical compounds
GB9301000D0 (en) Chemical compounds
GB9312210D0 (en) Chemical compounds
GB9305468D0 (en) Chemical compounds
GB9310635D0 (en) Chemical compounds
GB9305469D0 (en) Chemical compounds
GB9326192D0 (en) Chemical compounds
GB2280677B (en) Chemical compounds
GB9307749D0 (en) Chemical compounds
GB9305523D0 (en) Chemical compounds
GB9305510D0 (en) Chemical compounds
GB9305459D0 (en) Chemical compounds
GB9305806D0 (en) Chemical compounds
GB9306941D0 (en) Chemical compounds
GB9314977D0 (en) Chemical compounds
GB9308419D0 (en) Chemical compounds
GB9314978D0 (en) Chemical compounds
GB9302801D0 (en) Chemical compounds
GB9302800D0 (en) Chemical compounds
GB9301092D0 (en) Chemical compounds
GB9303573D0 (en) Chemical compounds
GB9300557D0 (en) Chemical compounds
GB9310884D0 (en) Chemical compounds
GB9303902D0 (en) Chemical compounds
GB9306457D0 (en) Chemical compounds